Paul Tudor Jones Eli Lilly & CO Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Eli Lilly & CO stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 45,300 shares of LLY stock, worth $36 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

45,300

Previous 1,510 2900.0%

Holding current value

$36 Million

Previous $1.37 Million 2835.84%

% of portfolio

0.15%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.09 Million - $1.37 Million	1,510 New	1,510 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $6.82 Million - $8.04 Million	12,993 Added 120.91%	23,739 $13.8 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $4.67 Million - $6.44 Million	10,746 New	10,746 $5.77 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $14.9 Million - $17.5 Million	-48,047 Reduced 75.97%	15,198 $5.22 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $13.8 Million - $16.1 Million	42,940 Added 211.48%	63,245 $23.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $9,783 - $11,149	33 Added 0.16%	20,305 $6.57 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $51,565 - $60,544	-185 Reduced 0.9%	20,272 $6.57 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2.12 Million - $2.64 Million	9,045 Added 79.26%	20,457 $5.86 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $344,020 - $426,931	1,530 Added 15.48%	11,412 $3.15 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $222,043 - $273,255	1,002 Added 11.28%	9,882 $2.28 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $8.82 Million - $11.4 Million	-48,843 Reduced 84.62%	8,880 $2.04 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $9.49 Million - $12.3 Million	57,723 New	57,723 $10.8 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.52 Million - $2.01 Million	-11,644 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $1.7 Million - $1.97 Million	11,644 New	11,644 $1.72 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $8.09 Million - $8.8 Million	-75,739 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $8.39 Million - $9.79 Million	75,739 New	75,739 $8.39 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $6.57 Million - $7.74 Million	-59,043 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.47 Million - $1.65 Million	-13,886 Reduced 19.04%	59,043 $6.83 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.87 Million - $2.34 Million	21,772 Added 42.56%	72,929 $7.83 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $273,655 - $314,071	3,615 Added 7.6%	51,157 $4.37 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $3.53 Million - $4.16 Million	47,542 New	47,542 $3.68 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account